RecruitingNot ApplicableNCT06997003

Evaluation of a New Laser Refractive Vision Correction Using the TENEO™ 317 Model 2

Evaluation of a New Customized Corneal Treatment for Laser Refractive Vision Correction Using the TENEO™ 317 Model 2

Sponsor

Bausch & Lomb GmbH

Enrollment

81 participants

Start Date

Jun 16, 2025

Study Type

INTERVENTIONAL

Conditions

Hyperopia and Myopia

Summary

Prospective, post market clinical follow up study with a three months postoperative follow up to evaluate the visual and refractive outcomes of OCTAVIUS treatment when used as intended.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Anterior treatment mode, a medical device called Anterior treatment mode, and others for people with hyperopia and myopia. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEAnterior treatment mode

Laser-in-situ-Keratomileusis (LASIK) surgery using OCTAVIUS treatment

DEVICEAnterior treatment mode

Laser-in-situ-Keratomileusis (LASIK) surgery using OCTAVIUS treatment

DEVICETotal treatment mode

Laser-in-situ-Keratomileusis (LASIK) surgery using OCTAVIUS treatment

Locations(1)

Site 01

Zlín, Czech Republic, Czechia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06997003

Related Trials

Eye Imaging for the Study of Childhood Myopia

NCT073351461 location

Algorithm-assisted Subjective Refraction Program Dedicated to Children

NCT070460651 location